SAN FRANCISCO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a company overview at two upcoming investor conferences.
- Piper Jaffray Healthcare Conference
The company will give a corporate presentation on Wednesday, November 28, 2018 at 1:30 p.m. ET. The conference will be held in New York, NY.
- BMO Healthcare Conference
The company will give a corporate presentation on Wednesday, December 12, 2018 at 11:00 a.m. ET. The conference will be held in New York, NY.
The presentations listed above are subject to change. Live audio webcasts of the presentations can be accessed through the Events & Presentations section of the company’s website at ir.eidostx.com. Archived replays of the webcasts will be available on the company’s website for 90 days following the live presentations.
About Eidos Therapeutics
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). For more information, please visit www.eidostx.com.
Media Contact:
Carolyn Hawley, Canale Communications, (619) 849-5382, [email protected]
For Investors
Alex Gray, Burns McClellan, (212) 213-0006, [email protected]
